Point72 Hong Kong’s Amphastar Pharmaceuticals AMPH Stock Holding History

Point72 Hong Kong’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-401	Closed	-$16K	–	451
2024 Q2	$16K	Sell	401 -1,999	-83%	-$82.8K	﹤0.01%	396
2024 Q1	$105K	Buy	+2,400	New	+$124K	0.01%	427
2022 Q4	–	Sell	-2,683	Closed	-$75K	–	134
2022 Q3	$75K	Sell	2,683 -2,112	-44%	-$69K	﹤0.01%	1312
2022 Q2	$167K	Buy	4,795 +2,725	+132%	+$97.2K	0.01%	1034
2022 Q1	$74K	Buy	+2,070	New	+$58.7K	﹤0.01%	1230
2021 Q4	–	Sell	-139	Closed	-$3K	–	1859
2021 Q3	$3K	Buy	+139	New	+$2.72K	﹤0.01%	1864
2019 Q4	–	Sell	-18	Closed	–	–	1131
2019 Q3	$0	Buy	+18	New	+$375	﹤0.01%	982
2018 Q3	–	Sell	-80	Closed	-$1K	–	873
2018 Q2	$1K	Sell	80 -57	-42%	-$996	﹤0.01%	810
2018 Q1	$3K	Buy	+137	New	+$2.58K	﹤0.01%	761

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Hong Kong's AMPH Position: Q3 2024 in Review

Point72 Hong Kong sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2024, closing a stake of 401 shares — an estimated $16K sold.

Point72 Hong Kong first reported a position in AMPH in Q1 2018 and held it in 9 quarters. The position peaked at $167K in Q2 2022. 279 funds tracked by Wall St. Rank hold AMPH as of Q3 2024.

Point72 Hong Kong reported no remaining Amphastar Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Point72 Hong Kong sold 401 Amphastar Pharmaceuticals shares in Q3 2024, an estimated $16K.
Point72 Hong Kong first reported a position in Amphastar Pharmaceuticals in Q1 2018 and held it in 9 quarters.
Point72 Hong Kong's Amphastar Pharmaceuticals position peaked at $167K in Q2 2022.
279 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2024.

Based on Point72 Hong Kong's 13F filing for Q3 2024, filed 14 Nov 2024.